1. Home
  2. OUSTZ vs VINC Comparison

OUSTZ vs VINC Comparison

Compare OUSTZ & VINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OUSTZ
  • VINC
  • Stock Information
  • Founded
  • OUSTZ N/A
  • VINC 2019
  • Country
  • OUSTZ United States
  • VINC United States
  • Employees
  • OUSTZ N/A
  • VINC N/A
  • Industry
  • OUSTZ Industrial Machinery/Components
  • VINC Biotechnology: Pharmaceutical Preparations
  • Sector
  • OUSTZ Industrials
  • VINC Health Care
  • Exchange
  • OUSTZ Nasdaq
  • VINC Nasdaq
  • Market Cap
  • OUSTZ 7.0M
  • VINC 6.2M
  • IPO Year
  • OUSTZ N/A
  • VINC N/A
  • Fundamental
  • Price
  • OUSTZ $0.10
  • VINC $0.15
  • Analyst Decision
  • OUSTZ
  • VINC Buy
  • Analyst Count
  • OUSTZ 0
  • VINC 2
  • Target Price
  • OUSTZ N/A
  • VINC $2.00
  • AVG Volume (30 Days)
  • OUSTZ N/A
  • VINC 21.3M
  • Earning Date
  • OUSTZ N/A
  • VINC 11-12-2024
  • Dividend Yield
  • OUSTZ N/A
  • VINC N/A
  • EPS Growth
  • OUSTZ N/A
  • VINC N/A
  • EPS
  • OUSTZ N/A
  • VINC N/A
  • Revenue
  • OUSTZ N/A
  • VINC N/A
  • Revenue This Year
  • OUSTZ N/A
  • VINC N/A
  • Revenue Next Year
  • OUSTZ N/A
  • VINC N/A
  • P/E Ratio
  • OUSTZ N/A
  • VINC N/A
  • Revenue Growth
  • OUSTZ N/A
  • VINC N/A
  • 52 Week Low
  • OUSTZ N/A
  • VINC $0.14
  • 52 Week High
  • OUSTZ N/A
  • VINC $9.37
  • Technical
  • Relative Strength Index (RSI)
  • OUSTZ N/A
  • VINC 37.12
  • Support Level
  • OUSTZ N/A
  • VINC $0.14
  • Resistance Level
  • OUSTZ N/A
  • VINC $0.52
  • Average True Range (ATR)
  • OUSTZ 0.00
  • VINC 0.04
  • MACD
  • OUSTZ 0.00
  • VINC -0.00
  • Stochastic Oscillator
  • OUSTZ 0.00
  • VINC 3.25

About VINC Vincerx Pharma Inc.

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.

Share on Social Networks: